Dermorphin
Also known as D-Ala2 dermorphin
A potent opioid heptapeptide originally isolated from frog skin secretions and studied as a tool compound for mu-opioid receptor pharmacology and analgesia research.
Overview
Dermorphin is a naturally occurring opioid peptide notable for its unusual D-amino-acid residue and very high affinity for mu-opioid receptors. It is primarily a research tool for opioid pharmacology rather than a general wellness peptide.
The Science
Dermorphin's potency comes from how its structure fits the mu-opioid receptor. That makes it scientifically important, but it also places it in a risk category very different from cosmetic, metabolic, or repair-oriented peptides.
- Analgesia research - used to probe opioid receptor signaling.
- Receptor selectivity - studied as a model for mu-opioid activity.
- Peptide stereochemistry - the D-amino-acid feature changes stability and receptor behavior.
- Doping and safety context - illicit use has appeared in animal sport and anti-doping discussions.
Evidence Snapshot
Dermorphin should be treated as a potent neuroactive opioid peptide. Component-level pharmacology is not a basis for casual self-experimentation, and claims around it require a much higher safety bar than most entries in this library.
Related
More in Cognitive
Adamax
Research compoundCognitive
A Semax-derived cognitive research peptide marketed in nootropic communities, with claims centered on neurotrophic signaling, focus, mood, and stress resilience.
Cerebrolysin
InvestigationalCognitive
A parenteral preparation of small peptides and amino acids derived from porcine brain protein, used clinically for decades across stroke, dementia, and traumatic brain injury recovery in many countries outside the US.
DSIP
Research compoundCognitive
A nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of slow-wave-sleeping rabbits — a decades-long scientific puzzle studied for effects on sleep, stress tolerance, and neuroendocrine signaling.